CT
Caldera Therapeutics, Inc.
SEC filingBiotechnology · Cambridge, MA
Amount raised$37.5Msold at filing
Total offering$37.5M
Investors in the raise3count reported to the SEC
FiledJan 21, 2026first sale Jan 8, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Michelle DoigDirector
Aaron RoystonDirector
Michael GladstoneDirector
Xiaodi SuDirector
Praveen TipirneniExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.